BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 26924632)

  • 1. Low Anti-Müllerian Hormone in Pediatric Cancer Survivors in the Early Years after Gonadotoxic Therapy.
    Elchuri SV; Patterson BC; Brown M; Bedient C; Record E; Wasilewski-Masker K; Mertens AC; Meacham LR
    J Pediatr Adolesc Gynecol; 2016 Aug; 29(4):393-9. PubMed ID: 26924632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian reserve after treatment with alkylating agents during childhood.
    Thomas-Teinturier C; Allodji RS; Svetlova E; Frey MA; Oberlin O; Millischer AE; Epelboin S; Decanter C; Pacquement H; Tabone MD; Sudour-Bonnange H; Baruchel A; Lahlou N; De Vathaire F
    Hum Reprod; 2015 Jun; 30(6):1437-46. PubMed ID: 25801499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimüllerian hormone as a measure of reproductive function in female childhood cancer survivors.
    Lunsford AJ; Whelan K; McCormick K; McLaren JF
    Fertil Steril; 2014 Jan; 101(1):227-31. PubMed ID: 24083876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of hydroxyurea and bone marrow transplant on Anti-Müllerian hormone (AMH) levels in females with sickle cell anemia.
    Elchuri SV; Williamson RS; Clark Brown R; Haight AE; Spencer JB; Buchanan I; Hassen-Schilling L; Brown MR; Mertens AC; Meacham LR
    Blood Cells Mol Dis; 2015 Jun; 55(1):56-61. PubMed ID: 25976468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-mullerian hormone in young women after chemotherapy and infradiaphragmatic radiotherapy for childhood cancer].
    Krawczuk-Rybak M; Leszczyńska E; Wysocka J; Zelazowska-Rutkowska B
    Pediatr Endocrinol Diabetes Metab; 2008; 14(2):99-103. PubMed ID: 18721496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Detection of Ovarian Dysfunction by Anti-Mullerian Hormone in Adolescent and Young Adult-Aged Survivors of Childhood Cancer.
    George SA; Williamson Lewis R; Schirmer DA; Effinger KE; Spencer JB; Mertens AC; Meacham LR
    J Adolesc Young Adult Oncol; 2019 Feb; 8(1):18-25. PubMed ID: 30281375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Müllerian Hormone in Female Adolescent Cancer Patients Before, During, and After Completion of Therapy: A Pilot Feasibility Study.
    Gupta AA; Lee Chong A; Deveault C; Traubici J; Maloney AM; Knight S; Lorenzo A; Allen L
    J Pediatr Adolesc Gynecol; 2016 Dec; 29(6):599-603. PubMed ID: 27184535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of cancer treatment on risk of infertility and diminished ovarian reserve in women with polycystic ovary syndrome.
    Shandley LM; Fothergill A; Spencer JB; Mertens AC; Cottrell HN; Howards PP
    Fertil Steril; 2018 Mar; 109(3):516-525.e1. PubMed ID: 29428311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum anti-Müllerian hormone as a marker of ovarian reserve after cancer treatment and/or hematopoietic stem cell transplantation in childhood: proposal for a systematic approach to gonadal assessment.
    Molinari S; Parissone F; Evasi V; De Lorenzo P; Valsecchi MG; Cesaro S; Fraschini D; Sangalli R; Cacace G; Biondi A; Balduzzi A; Cattoni A
    Eur J Endocrinol; 2021 Oct; 185(5):717-728. PubMed ID: 34519276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of ovarian reserve in adult childhood cancer survivors using anti-Müllerian hormone.
    Lie Fong S; Laven JS; Hakvoort-Cammel FG; Schipper I; Visser JA; Themmen AP; de Jong FH; van den Heuvel-Eibrink MM
    Hum Reprod; 2009 Apr; 24(4):982-90. PubMed ID: 19153092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Female adolescents and young women previously treated for pediatric malignancies: assessment of ovarian reserve and gonadotoxicity risk stratification for early identification of patients at increased infertility risk.
    Parissone F; Di Paola R; Balter R; Garzon S; Zaffagnini S; Neri M; Vitale V; Tridello G; Cesaro S
    J Pediatr Endocrinol Metab; 2021 Jan; 34(1):25-33. PubMed ID: 33068384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of cancer therapies on ovarian reserve.
    Gracia CR; Sammel MD; Freeman E; Prewitt M; Carlson C; Ray A; Vance A; Ginsberg JP
    Fertil Steril; 2012 Jan; 97(1):134-40.e1. PubMed ID: 22137491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring ovarian function in young cancer survivors.
    Su HI
    Minerva Endocrinol; 2010 Dec; 35(4):259-70. PubMed ID: 21178920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Müllerian hormone screening to assess ovarian reserve among female survivors of childhood cancer.
    Charpentier AM; Chong AL; Gingras-Hill G; Ahmed S; Cigsar C; Gupta AA; Greenblatt E; Hodgson DC
    J Cancer Surviv; 2014 Dec; 8(4):548-54. PubMed ID: 24810980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoandrogenism in association with diminished functional ovarian reserve.
    Gleicher N; Kim A; Weghofer A; Kushnir VA; Shohat-Tal A; Lazzaroni E; Lee HJ; Barad DH
    Hum Reprod; 2013 Apr; 28(4):1084-91. PubMed ID: 23427231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure.
    Knauff EA; Eijkemans MJ; Lambalk CB; ten Kate-Booij MJ; Hoek A; Beerendonk CC; Laven JS; Goverde AJ; Broekmans FJ; Themmen AP; de Jong FH; Fauser BC;
    J Clin Endocrinol Metab; 2009 Mar; 94(3):786-92. PubMed ID: 19066296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Premature Ovarian Insufficiency in Childhood Cancer Survivors: A Report From the St. Jude Lifetime Cohort.
    Chemaitilly W; Li Z; Krasin MJ; Brooke RJ; Wilson CL; Green DM; Klosky JL; Barnes N; Clark KL; Farr JB; Fernandez-Pineda I; Bishop MW; Metzger M; Pui CH; Kaste SC; Ness KK; Srivastava DK; Robison LL; Hudson MM; Yasui Y; Sklar CA
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2242-2250. PubMed ID: 28368472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD).
    Giuseppe L; Attilio G; Edoardo DN; Loredana G; Cristina L; Vincenzo L
    Hematology; 2007 Apr; 12(2):141-7. PubMed ID: 17454195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener's).
    Clowse ME; Copland SC; Hsieh TC; Chow SC; Hoffman GS; Merkel PA; Spiera RF; Davis JC; McCune WJ; Ytterberg SR; St Clair EW; Allen NB; Specks U; Stone JH;
    Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1777-81. PubMed ID: 22127969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling Variation in the Reproductive Lifespan of Female Adolescent and Young Adult Cancer Survivors Using AMH.
    Su HI; Kwan B; Whitcomb BW; Shliakhsitsava K; Dietz AC; Stark SS; Martinez E; Sluss PM; Sammel MD; Natarajan L
    J Clin Endocrinol Metab; 2020 Aug; 105(8):2740-51. PubMed ID: 32270202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.